Company facts, press assets, approved language, and media contacts for journalists covering AI health, dermatology access, and consumer triage.
2024
public launch
15
condition pages
30 sec
guidance target
Approved positioning
AI guidance, not diagnosis.
Safety note
Please preserve the medical disclaimer in coverage.
Boilerplate
Use this language when describing DermAI in articles, interviews, product roundups, and partner announcements.
DermAI is an AI-assisted skin scan platform that helps people photograph visible skin concerns and receive condition probability guidance, urgency triage, and practical next steps. DermAI is designed for first-step clarity and appointment preparation. It does not diagnose, prescribe, treat, or replace qualified dermatology care.
Product
AI-assisted skin scan guidance
Audience
Consumers, families, clinics, telehealth teams
Core promise
Condition probability, urgency, and next steps in under 30 seconds
Medical position
Wellness guidance, not diagnosis or treatment
Launch library
15 condition pages live, 30+ planned
Headquarters
U.S.-focused, global-ready digital health product
Story angles
DermAI's story sits at the intersection of access, careful AI language, privacy-conscious image handling, and dermatology workflow support.
Media kit
The media kit is represented here as a live-ready asset checklist. Production can wire these buttons to a ZIP download once final files are approved.
Primary mark, icon mark, dark-background lockup, and spacing guidance for editorial use.
Homepage, scan flow, results report, condition library, dashboard, pricing, and clinic workflows.
Founder portraits, clinical advisor headshots, and product team photos for launch stories.
Company summary, product positioning, safety language, facts, and approved boilerplate.
Press releases
The press room keeps company milestones, launch notes, and approved public language in one place for journalists and partners.
DermAI does not diagnose.
The product provides wellness information, probability estimates, and urgency guidance. Seek qualified medical care for diagnosis, treatment, rapidly changing symptoms, severe pain, fever, bleeding, infection signs, or any urgent concern.
The updated public site adds live-ready education pages, a guided scan workflow, trust and privacy language, and care-navigation content for consumers and partner teams.
The clinic experience frames AI as structured intake support, with urgency routing, report exports, consent language, and workflow handoff for care teams.
The first public positioning focused on probability language, medical disclaimers, image privacy, and prompt care guidance for users worried about visible skin changes.
Approved quotes
These quotes can be used with attribution in coverage after confirming the final story context with the DermAI communications team.
"The important question is not whether AI can sound certain. It is whether it can help someone choose a safer next step."
Claire Holloway
Founder and CEO
"DermAI keeps uncertainty visible because skin images rarely tell the whole clinical story on their own."
Molly Keene
Clinical product lead
"Our privacy posture starts from a simple assumption: skin photos deserve sensitive-data handling from day one."
Eric Sanders
Security and platform lead
For interviews, screenshots, clinical advisor availability, founder background, or media kit access, contact the DermAI press team.
press@dermai.skinCover DermAI responsibly
Read the public story, review the medical disclaimer, or contact the team for approved assets.
